A Multicenter, dOuble-blind, ranDomized, placebo-controlled, parallel-group study to determine the effIcacy and safety of lucerastat oral monotherapy in adult subjects with FabrY disease.

Administered By

Awarded By

Contributors

Start/End

  • August 6, 2020 - September 9, 2021